Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis

Neurology

Volumn 75, Issue 17, 2010, Pages 1533-1539

  Brouwer, M C ^a   Heckenberg, S G B ^a   De Gans, J ^a   Spanjaard, L ^b   Reitsma, J B ^b   Van De Beek, D ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; DEXAMETHASONE; PENICILLIN G;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APHASIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; DRUG EFFICACY; FEMALE; GLASGOW OUTCOME SCALE; HEARING LOSS; HEMIPARESIS; HUMAN; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; PATIENT COMPLIANCE; PNEUMOCOCCAL MENINGITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DEXAMETHASONE; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; MALE; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78149254805     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f96297     Document Type: Article

References (24)

1. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-1859.
2. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006;5:123-129.
3. Tauber MG, Khayam-Bashi H, Sande MA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985;151:528-534.
4. Scheld WM, Dacey RG, Winn HR, Welsh JE, Jane JA, Sande MA. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis: alterations with penicillin and methylprednisolone. J Clin Invest 1980;66:243-253.
5. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-1556.
6. Scarborough M, Gordon SB, Whitty CJ, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007;357:2441-2450.
7. Nguyen TH, Tran TH, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007;357:2431-2440.
8. Peltola H, Roine I, Fernandez J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007;45:1277-1286.
9. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002;360:211-218.
10. van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010;9:254-263.
11. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med 2006;354:44-53.
12. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-1284.
13. Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of communityacquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008;15:649-659.
14. Statistics Netherlands. Statline, Voorburg/Heerlen, 2001. Available at: www.cbs.nl. Accessed June 13, 2009.
15. Jennett B, Teasdale G. Management of Head Injuries., 2 ed. Philadelphia: FA Davis; 1981.
16. Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis: an analysis of the predictive value of initial observations. JAMA 1989;262:2700-2707.
17. van de Beek D, de Gans J, Spanjaard L, Vermeulen M, Dankert J. Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother 2002;49:661-666.
18. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-1886.
19. MacLehose RR, Reeves BC, Harvey IM, Sheldon TA, Russell IT, Black AM. A systematic review of comparisons of effect sizes derived from randomised and nonrandomised studies. Health Technol Assess 2000;4:1-154.
20. Miettinen OS. The need for randomization in the study of intended effects. Stat Med 1983;2:267-271.
21. Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLoS Med 2008;5: e67.
22. Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 2005;41(suppl 7):S504-S512.
23. Mai NTH, Hoa NT, Nga TVT, et al. Streptococcus suis meningitis in adults in Vietnam. Clin Infect Dis 2008;46:659-667.
24. Swartz MN. Bacterial meningitis: a view of the past 90 years. N Engl J Med 2004;351:1826-1828.